BDBM72351 3-(3-chlorophenyl)azo-5,7-dimethyl-2-pyrazolo[1,5-a]pyrimidinamine::3-[(3-chlorophenyl)diazenyl]-5,7-dimethyl-pyrazolo[1,5-a]pyrimidin-2-amine::3-[(3-chlorophenyl)diazenyl]-5,7-dimethylpyrazolo[1,5-a]pyrimidin-2-amine::MLS000701175::SMR000226411::[3-(3-chlorophenyl)azo-5,7-dimethyl-pyrazolo[1,5-a]pyrimidin-2-yl]amine::cid_7203716

SMILES Cc1c(F)ccc2c1CNCCc1[nH]c(=O)ccc1N1CN2c2cc(F)c(F)cc2C1=O

InChI Key InChIKey=AYTMKTRTLCIZGP-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72351   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72351BDBM72351(2,3,8-Trifluoro-9-methyl-10,11,12,13-tetrahydro-19...)
Affinity DataIC50: 20nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
US Patent